Is a complete ADCT research report available?

No complete published report is available for ADC Therapeutics SA (ADCT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ADC Therapeutics SA (ADCT)

NYSE: ADCT · USD

$1.15

-0.07 (-5.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ADCT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	146.3M
Revenue (ttm)	79.2M
Net income (ttm)	-137M
EPS (ttm)	-$1.08
Shares out	127.2M
Volume	725,724
Beta	1.88
Price target	$5.00	+334.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 79.2M
Net income (ttm): -137M
EPS (ttm): -$1.08
Market cap: 146.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ADCT indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000061478
Company name	ADC Therapeutics SA
Country	Switzerland
Country code	US
Cusip	H0036K147
Employees	193
Employees Change	-72%
Employees Change Percent	-27.17
Enterprise value	$355.3M
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.6
Industry PE Fwd	14.1
IPO Date	2020-05-15
Isin	CH0499880968
Last refreshed	2026-07-25
Market cap	$146.3M
Market cap category	Micro-Cap
Price	$1.15
Price currency	USD
Rev Per Employee	410,233.16x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	3661
Symbol	ADCT
Website	https://www.adctherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-91.27%
EV Sales Forward	4.39x
EV/Sales	4.49x
FCF yield	-76.34%
P/S ratio	1.9x
PS Forward	1.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-149.39%
EBITDA Margin	-148.35%
Gross margin	-26.33%
Gross Profit	$-20.8M
Net Income	$-137M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	-171.95%
Profit Margin	-173.02%
Profit Per Employee	$-709,788
ROA	-22.73
Roa5y	-22.35
ROCE	-52.83
ROIC	-29.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.09%
Cagr3y	-6.79%
Cagr5y	-44.36%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth	4.43x
Revenue Growth Q	-9.47x
Revenue Growth Years	2x
Revenue Growth3 Y	-24.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.28
Assets	$291.5M
Cash	$231M
Current Assets	$276.8M
Current Liabilities	$67.6M
Debt	$436.3M
Equity	$-216.4M
Interest Coverage	-2.29
Liabilities	$507.9M
Long Term Assets	$14.7M
Long Term Liabilities	$440.2M
Net Cash	$-205.3M
Net Cash By Market Cap	$-137
Tangible Book Value	$-216.4M
Tangible Book Value Per Share	$-1.7
WACC	10.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.09
Inventory Turnover	9
Net Working Capital	$-2.3M
Quick ratio	3.87
Working Capital	$209.1M
Working Capital Turnover	$0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.06%
200-day SMA	3.43
3Y total return	-19.01%
50-day SMA	1.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.66%
All Time High	56.59
All Time High Change	-97.97%
All Time High Date	2020-07-02
All Time Low	0.36
All Time Low Change	219.53%
All Time Low Date	2023-11-13
ATR	0.12
Beta	1.88
Beta1y	2.53
Beta2y	2.36
Ch YTD	-67.42
High	1.26
High52	4.98
High52 Date	2026-03-11
High52ch	-76.91%
Low	1.15
Low52	0.78
Low52 Date	2026-06-08
Low52ch	47.51%
Ma50ch	-36.53%
Premarket Change Percent	0.82
Premarket Price	$1.23
Premarket Volume	741
Price vs 200-day SMA	-66.47%
RSI	34.27
RSI Monthly	34.89
RSI Weekly	27.87
Sharpe ratio	-0.6x
Sortino ratio	-0.66
Total Return	-23.08%
Tr YTD	-67.42
Tr1w	-14.81%
Tr3m	-70.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	4
Analyst Price Target Top	$5.67
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.21
Earnings Revenue Estimate	19,530,480x
Earnings Revenue Estimate Growth	3.67x
Operating Income	$-102.6M
Operating margin	-129.6
Price target	$5
Price Target Change	$335
Price Target Change Top	$393

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100,411,697%
Float Percent	78.95%
Shares Insiders	3.85%
Shares Institutions	42.26%
Shares Out	127,191,158
Shares Qo Q	-15.39%
Shares Yo Y	23.08%
Short Float	5.97%
Short Ratio	1.79
Short Shares	4.71

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-121.5M
Average Volume	1,232,963.1x
Bv Per Share	-1.7
CAPEX	$-32,000
Ch1w	-14.81
Ch1y	-64.06
Ch3m	-70.96
Ch3y	-19.01
Ch5y	-94.66
Ch6m	-68.14
Change	-5.74%
Change From Open	-8
Close	1.22
Days Gap	2.46
Depreciation Amortization	539,250
Dollar Volume	834,582.6
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-118.3M
EBITDA	$-117.5M
EPS	$-1.08
F Score	4
FCF	$-114.6M
FCF EV Yield	-32.25x
FCF Per Share	$-0.9
Financing CF	150,091,000
Fiscal Year End	December
Founded	2,011
Income Tax	$850,000
Investing CF	627,000
Ipr	-93.79
Iprfo	-96.07
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Ma150	3.19
Ma150ch	-63.97%
Ma20	1.23
Ma20ch	-6.2%
Net CF	36,307,000
Next Earnings Date	2026-08-11
Open	1.25
Optionable	Yes
Position In Range	4.35
Post Close	1.15
Postmarket Change Percent	1.3
Postmarket Price	$1.17
Ppne	1,200,000
Pre Close	1.22
Price Date	2026-07-24
Relative Volume	0.59x
Revenue	79,175,000x
SBC By Revenue	8.75x
Share Based Comp	6,926,000
Tax By Revenue	1.07x
Tr6m	-68.14%
Volume	725,724
Z Score	-7.59

ADC Therapeutics SA (ADCT)

Coverage state: Market snapshot only — no published research

Generate the first ADCT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ADCT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADCT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ADCT

Frequently asked questions